- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01885520
Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Eperisone HCl SR Tablet 75mg (eperisone)
March 23, 2016 updated by: NVP Healthcare
A Randomized,Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Eperisone HCl SR Tablet 75mg After Oral Administration in Healthy Adult Male Subjects.
The purpose of this study is to evaluate the food effect on the pharmacokinetics of eperisone HCl SR tablet
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
eperisone hydrochloride(muscle relaxant)
Study Type
Interventional
Enrollment (Actual)
28
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Daegu
-
Jung-gu, Daegu, Korea, Republic of, 700-721
- Kyungpook National University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 55 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Healthy male subjects age between 20 and 55 signed informed consent
Exclusion Criteria:
- Hypotension or hypertension has a history of allergy reaction of this drug or other drugs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: fasting condition
eperisone SR administrated under fasting condition
|
eperisone SR tablet 75mg administrated under fasting
|
|
Active Comparator: Fed condition
eperisone SR administrated under fed condition
|
eperisone SR tablet 75mg administrated fed condition
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Cmax
Time Frame: 0-24h
|
0-24h
|
|
AUC
Time Frame: 0-24h
|
0-24h
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
T1/2
Time Frame: 0-24h
|
0-24h
|
|
Tmax
Time Frame: 0-24h
|
0-24h
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Yoon Yo Ran, M.D., Ph.D., Kyungpook National University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2013
Primary Completion (Actual)
July 1, 2013
Study Completion (Actual)
July 1, 2013
Study Registration Dates
First Submitted
June 15, 2013
First Submitted That Met QC Criteria
June 24, 2013
First Posted (Estimate)
June 25, 2013
Study Record Updates
Last Update Posted (Estimate)
March 25, 2016
Last Update Submitted That Met QC Criteria
March 23, 2016
Last Verified
March 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NVP-EPT-PK-02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Low Back Pain
-
University of Kansas Medical CenterCompletedLower Back Pain | Low Back Pain | Low Back Pain, Mechanical | Low Back Pain, Recurrent | Low Back Pain, Postural | Postural Low Back Pain | Mechanical Low Back Pain | Low Back Ache | Recurrent Low Back Pain | Lower Back Pain Chronic | Low Back Pain, Posterior Compartment | Low BackacheUnited States
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Faculdade de Ciências Médicas da Santa Casa de...CompletedLow Back Pain, Mechanical | Low Back Pain, Postural | Lower Back Pain Chronic | Low Back Pain, Posterior CompartmentBrazil
-
Istanbul UniversityIstinye UniversityCompletedLow Back Pain | Low Back Pain, Mechanical | Low Back Pain, Recurrent | Low Back Pain, PosturalTurkey
-
University School of Physical Education in WroclawCompletedLow Back Pain | Low Back Pain, Mechanical | Low Back Pain, PosturalPoland
-
General Incorporated Foundation Ryukyuseimeisaiseikai...CompletedChronic Low Back Pain | Non-specific Low Back Pain | Low Back Pain (LBP)Japan
-
Texas Woman's UniversityTexas Physical Therapy AssociationCompletedLow Back Pain | Chronic Low Back Pain | Subacute Low Back PainUnited States
-
University of ParmaKing's College London; Helmholtz Zentrum München; GENOS; Ip Research Consulting... and other collaboratorsUnknownChronic Low Back Pain | Acute Low Back PainUnited States, Australia, Belgium, Croatia, Italy, United Kingdom
-
Pamukkale UniversityCompletedLow Back Disorder | Low Back Pain (LBP)Turkey
-
MMJ Labs LLCNational Institute on Drug Abuse (NIDA); Sport and Spine Rehab Clinical Research...CompletedChronic Low-back Pain | Pain, Intractable | Acute Low-back PainUnited States
Clinical Trials on fasting condition
-
University of British ColumbiaRecruitingGlucose Tolerance | Fasting | Immune FunctionCanada
-
University of LausanneEmpa - Swiss Federal Laboratories for Materials Testing and Research, ZürichCompleted
-
UCB Biopharma SRLCompleted
-
Aelis FarmaNational Institute on Drug Abuse (NIDA)TerminatedMarijuana AbuseUnited States
-
GeropharmCompletedBioequivalenceRussian Federation
-
GeropharmCompleted
-
Kasr El Aini HospitalCompleted
-
Cardenal Herrera UniversityCompletedChronic Low-back Pain (cLBP)Spain
-
UMC UtrechtDutch Heart FoundationNot yet recruitingHeart Failure NYHA Class II | Heart Failure NYHA Class III
-
Rutgers, The State University of New JerseyRecruitingAggression | Problem Behavior | Self InjuryUnited States